All Stories

  1. DNAJA1 dysregulates metabolism promoting an anti-apoptotic phenotype in pancreatic ductal adenocarcinoma
  2. Phosphorus NMR and Its Application to Metabolomics
  3. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics
  4. Evaluation of Multivariate Classification Models for Analyzing NMR Metabolomics Data
  5. Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity
  6. Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth
  7. O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3
  8. Functional Evolution of Proteins
  9. Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection
  10. Insights into gemcitabine resistance and the potential for therapeutic monitoring
  11. Combining Mass Spectrometry and NMR Improves Metabolite Detection and Annotation
  12. Comparing normalization methods and the impact of noise
  13. Expanding the Coverage of the Metabolome with Nitrogen-Based NMR
  14. 15 N CEST data and traditional model-free analysis capture fast internal dynamics of DJ-1
  15. Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility
  16. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
  17. Nanoformulated Copper/Zinc Superoxide Dismutase Exerts Differential Effects on Glucose versus Lipid Homeostasis Depending on the Diet Composition Possibly via Altered AMPK Signaling
  18. New frontiers in metabolomics: from measurement to insight
  19. Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
  20. Assessment of Metabolic Changes in Mycobacterium smegmatis Wild-Type and alr Mutant Strains: Evidence of a New Pathway of d-Alanine Biosynthesis
  21. Amino Acid Catabolism in Staphylococcus aureus and the Function of Carbon Catabolite Repression
  22. Identification of a Ligand-Binding Site on the Staphylococcus aureus DnaG Primase C-Terminal Domain
  23. PCA as a Practical Indicator of OPLS-DA Model Reliability
  24. Deterministic multidimensional nonuniform gap sampling
  25. Staphylococcus aureus Metabolic Adaptations during the Transition from a Daptomycin Susceptibility Phenotype to a Daptomycin Nonsusceptibility Phenotype
  26. Meet Our Editor
  27. Preface: “The Whole is Greater Than the Sum of its Parts.” - Aristotle
  28. Faculty of 1000 evaluation for Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
  29. Editorial
  30. Simultaneous phase and scatter correction for NMR datasets
  31. Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes
  32. Growth and Preparation of Staphylococcus epidermidis for NMR Metabolomic Analysis
  33. NMR Metabolomics Analysis of Parkinson's Disease
  34. Faculty of 1000 evaluation for Digestion and depletion of abundant proteins improves proteomic coverage.
  35. Faculty of 1000 evaluation for Metabolite-enabled eradication of bacterial persisters by aminoglycosides.
  36. NMR in Drug Discovery – Introduction
  37. Fragment Screen
  38. SAR by NMR
  39. The Applicability of Molecular Descriptors for Designing an Electrospray Ionization Mass Spectrometry Compatible Library for Drug Discovery
  40. Editorial
  41. Editorial
  42. Multivariate Analysis in Metabolomics
  43. Multivariate Analysis in Metabolomics
  44. Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies
  45. Application of NMR Metabolomics to Search for Human Disease Biomarkers
  46. Analysis of bacterial biofilms using NMR-based metabolomics
  47. Predicting the in Vivo Mechanism of Action for Drug Leads Using NMR Metabolomics
  48. An inexpensive high-throughput nuclear magnetic resonance tube cleaning apparatus
  49. Faculty of 1000 evaluation for Paper spray for direct analysis of complex mixtures using mass spectrometry.
  50. Bacterial protein structures reveal phylum dependent divergence
  51. Faculty of 1000 evaluation for A transient and low-populated protein-folding intermediate at atomic resolution.
  52. Faculty of 1000 evaluation for Enzymatic transition states and dynamic motion in barrier crossing.
  53. Faculty of 1000 evaluation for Molecular docking and ligand specificity in fragment-based inhibitor discovery.
  54. Faculty of 1000 evaluation for Evaluation of virtual screening as a tool for chemical genetic applications.
  55. Faculty of 1000 evaluation for Mapping of ligand-binding cavities in proteins.
  56. Faculty of 1000 evaluation for A hybrid clustering of protein binding sites.
  57. Analysis of metabolomic PCA data using tree diagrams
  58. Faculty of 1000 evaluation for Systems biology: an evolving approach in drug discovery and development.
  59. Advances in nuclear magnetic resonance for drug discovery
  60. Faculty of 1000 evaluation for Structure and energetics of the hydrogen-bonded backbone in protein folding.
  61. NMR metabolomics and drug discovery
  62. Faculty of 1000 evaluation for Metabolite identification via the Madison Metabolomics Consortium Database.
  63. Faculty of 1000 evaluation for Binding similarity network of ligand.
  64. Faculty of 1000 evaluation for Protein dispensability and rate of evolution.
  65. Functional Genomics and NMR Spectroscopy
  66. Faculty of 1000 evaluation for Enzyme function less conserved than anticipated.
  67. Faculty of 1000 evaluation for Intrinsic errors in genome annotation.
  68. Faculty of 1000 evaluation for Discovering high-affinity ligands for proteins: SAR by NMR.
  69. Faculty of 1000 evaluation for Evolutionary rate in the protein interaction network.
  70. APPLICATIONS OF NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY TO ANTICANCER DRUG DISCOVERY
  71. Solution structure of the tumor necrosis factor receptor-1 death domain
  72. Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using nitrogen-15 relaxation measurements
  73. Three-Dimensional Solution Structure of Human Interleukin-4 by Multidimensional Heteronuclear Magnetic Resonance Spectroscopy
  74. Proton, nitrogen-15, carbon-13, carbon-13 monoxide assignments of human interleukin-4 using three-dimensional double- and triple-resonance heteronuclear magnetic resonance spectroscopy
  75. Determination of the secondary structure and folding topology of human interleukin-4 using three-dimensional heteronuclear magnetic resonance spectroscopy
  76. Secondary structure of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase in solution using three-dimensional double and triple resonance heteronuclear magnetic resonance spectroscopy
  77. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams
  78. Three-dimensional triple-resonance NMR of 13C/15N-enriched proteins using constant-time evolution
  79. Two-dimensional proton and phosphorus-31 NMR spectra and restrained molecular dynamics structure of a covalent CPI-CDPI2-oligodeoxyribonucleotide decamer complex
  80. Introduction to NMR and Its Application in Metabolite Structure Determination